Announced
Financials
Tags
De-SPAC
Single Bidder
Pending
Private
biotechnology company
Brazil
Acquisition
Biotechnology
Friendly
Cross Border
Reverse Takeover
Majority
Synopsis
SuperBac Biotechnology Solutions, a biotech company in Brazil, agreed to go public via merger with XPAC Acquisition, a publicly-traded special purpose acquisition company, in a $500m deal. "We believe that our target segments within the biotechnology market have significant potential to expand in the coming years, and that with this business combination, SuperBac is very well positioned to capitalize on growth opportunities. We understand that innovation and technology play a strategic role in driving sustainable growth and redefining the future of biotechnology, and SuperBac is at the forefront of this movement," Luiz Chacon, SuperBac Founder and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.